Key facts
| Price (PPV) | 115.90 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | amoxicilline acide clavulanique |
| Class | Antibacterials for systemic use |
| ATC code | J01CR02 |
| Manufacturer | LAPROPHAN |
| Presentation | Boîte de 16 |
| Nature | Médicament |
| Hospital price | 72.40 MAD |
| Data collected on | 9/8/2026 |
Indications
Traitement des infections suivantes chez les adultes et les enfants: - sinusite bactérienne aiguë (diagnostiquée de façon appropriée), - otite moyenne aiguë, - exacerbations aiguës de bronchite chronique (diagnostiquée de façon appropriée), - pneumonie aiguë communautaire, - cystite, - pyélonéphrite, - infections de la peau et des tissus mous, en particulier cellulite, morsures animales, abcès dentaire sévère avec propagation de cellulite, - infections des os et des articulations, en particulier ostéomyélite. Il convient de tenir compte des recommandations officielles concernant l’utilisation appropriée des antibactériens.
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
Levamox 1 g / 125 mg (LAPROPHAN) contains the same active substance as Levamox 1 g / 125 mg (Amoxicilline Acide clavulanique) at the same strength, but in a different pack: Boîte de 12 at 86.90 MAD, i.e. 7.24 MAD per unit against 7.24 MAD for Levamox 1 g / 125 mg. The public sale price is set by the Ministry of Health: it is identical in every pharmacy.
| Product | Manufacturer | Pack | PPV | Unit price |
|---|---|---|---|---|
| Levamox 1 g / 125 mg | LAPROPHAN | Boîte de 12 | 86.90 MAD | 7.24 / unit |
| Soclav 1 g / 125 mg | SOTHEMA | Boîte de 12 | 86.90 MAD | 7.24 / unit |
| Zamox 1 g / 125 mg | BOTTU S.A. | Boite de 14 | 101.90 MAD | 7.28 / unit |
| Zamox 1 g / 125 mg | BOTTU S.A. | Boite de 21 | 141.10 MAD | 6.72 / unit |
| Soclav 1 g / 125 mg | SOTHEMA | Boite de 24 | 153 MAD | 6.38 / unit |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Levamox 1 g / 125 mg
Levamox 1 g / 125 mg belongs to the antibacterials for systemic use therapeutic class. In Morocco, this drug is marketed by LAPROPHAN and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Levamox 1 g / 125 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Levamox 1 g / 125 mg
Answers to common questions from Moroccan patients about this drug.